Assignee
PHARNEXT
FR·44 granted patents·17 pending applications·162 citations·filing 2010–2023
Top patents by PatentIndex Score
61 records- 0197US9566275B2Compositions for treating CMT and related disordersPHARNEXT·Filed 2016·Granted Feb 14, 2017·13 cites·14 claims
- 0296US9393241B2Compositions for treating CMT and related disordersPHARNEXT·Filed 2014·Granted Jul 19, 2016·14 cites·11 claims
- 0396US9241933B2Compositions for treating amyotrophic lateral sclerosisPHARNEXT·Filed 2014·Granted Jan 26, 2016·16 cites·16 claims
- 0494US9427436B1Compositions for treating CMT and related disordersPHARNEXT·Filed 2016·Granted Aug 30, 2016·14 cites·5 claims
- 0594US8741886B2Baclofen and acamprosate based therapy of neurological disordersPHARNEXT·Filed 2012·Granted Jun 3, 2014·20 cites·17 claims
- 0693US8865769B2Baclofen and acamprosate based therapy of neurological disordersPHARNEXT·Filed 2012·Granted Oct 21, 2014·15 cites·10 claims
- 0790US10342784B2Compositions for treating amyotrophic lateral sclerosisPHARNEXT·Filed 2018·Granted Jul 9, 2019·2 cites·16 claims
- 0890US10322101B2Therapeutic approaches for treating CMT and related disordersPHARNEXT·Filed 2018·Granted Jun 18, 2019·2 cites·9 claims
- 0990US10045971B2Compositions for treating amyotrophic lateral sclerosisPHARNEXT·Filed 2016·Granted Aug 14, 2018·3 cites·15 claims
- 1089US9636316B2Baclofen and acamprosate based therapy of neurological disordersPHARNEXT·Filed 2015·Granted May 2, 2017·5 cites·15 claims
- 1189US9144558B2Baclofen and acamprosate based therapy of neurological disordersPHARNEXT·Filed 2014·Granted Sep 29, 2015·8 cites·42 claims
- 1288US10092554B2Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose levelPHARNEXT·Filed 2015·Granted Oct 9, 2018·3 cites·13 claims
- 1388US10010515B2Therapeutic approaches for treating Parkinson's diseasePHARNEXT·Filed 2016·Granted Jul 3, 2018·3 cites·20 claims
- 1488US9931326B2Composition comprising torasemide and baclofen for treating neurological disordersPHARNEXT·Filed 2014·Granted Apr 3, 2018·5 cites·6 claims
- 1587US10463640B2Therapeutic approaches for treating CMT and related disordersPHARNEXT·Filed 2018·Granted Nov 5, 2019·1 cites·9 claims
- 1687US10441558B2Therapeutic approaches for treating CMT and related disordersPHARNEXT·Filed 2018·Granted Oct 15, 2019·1 cites·9 claims
- 1786US10342768B2Therapeutic approaches for treating Parkinson's diseasePHARNEXT·Filed 2015·Granted Jul 9, 2019·2 cites·24 claims
- 1885US10905686B2Compositions for treating CMT and related disordersPHARNEXT·Filed 2018·Granted Feb 2, 2021·1 cites·25 claims
- 1985US10300015B2Stable oral solutions for combined APIPHARNEXT·Filed 2014·Granted May 28, 2019·8 cites·20 claims
- 2085US9387206B2Therapeutic approaches for treating Alzheimer's diseasePHARNEXT·Filed 2014·Granted Jul 12, 2016·3 cites·8 claims
- 2185US9248111B2Therapeutic approaches for treating parkinson's diseasePHARNEXT·Filed 2014·Granted Feb 2, 2016·6 cites·23 claims
- 2283US10583135B2Compositions for treating CMT and related disordersPHARNEXT·Filed 2016·Granted Mar 10, 2020·1 cites·24 claims
- 2382US10849851B2Stable oral solutions for combined APIPHARNEXT·Filed 2019·Granted Dec 1, 2020·1 cites·35 claims
- 2482US2023233552A1Compositions for treating cmt and related disordersPHARNEXT·Filed 2023·Application pending·0 cites
- 2581US10940147B2Early treatment of CMT diseasePHARNEXT·Filed 2019·Granted Mar 9, 2021·1 cites·18 claims
- 2681US10434109B2Compositions for treating neurological disordersPHARNEXT·Filed 2018·Granted Oct 8, 2019·2 cites·7 claims
- 2779US10383870B2Early treatment of CMT diseasePHARNEXT·Filed 2017·Granted Aug 20, 2019·1 cites·17 claims
- 2879US10004744B2Therapeutic approaches for treating Parkinson's diseasePHARNEXT·Filed 2013·Granted Jun 26, 2018·3 cites·12 claims
- 2979US9867837B2Compositions for treating neurological disordersPHARNEXT·Filed 2013·Granted Jan 16, 2018·3 cites·9 claims
- 3077US2020155491A1Therapeutic approaches for treating cmt and related disordersPHARNEXT·Filed 2019·Application pending·0 cites
- 3175US11672796B2Compositions for treating CMT and related disordersPHARNEXT·Filed 2020·Granted Jun 13, 2023·0 cites·25 claims
- 3275US10682342B2Compositions for treating amyotrophic lateral sclerosisPHARNEXT·Filed 2019·Granted Jun 16, 2020·0 cites·14 claims
- 3373US10905672B2Combination of baclofen, acamprosate and medium chain triglycerides for the treatment of neurological disordersPHARNEXT·Filed 2015·Granted Feb 2, 2021·1 cites·15 claims
- 3472US11576908B2Compositions for treating CMT and related disordersPHARNEXT·Filed 2020·Granted Feb 14, 2023·0 cites·17 claims
- 3572US10874644B2Therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of synapse functionPHARNEXT·Filed 2019·Granted Dec 29, 2020·0 cites·7 claims
- 3672US10799499B2Combinatorial therapies of neurological disordersPHARNEXT·Filed 2017·Granted Oct 13, 2020·1 cites·19 claims
- 3772US9597297B2Combination of pilocarpin and methimazol for treating Charcot-Marietooth disease and related disordersPHARNEXT·Filed 2014·Granted Mar 21, 2017·1 cites·9 claims
- 3871US10350195B2Therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of synapse functionPHARNEXT·Filed 2015·Granted Jul 16, 2019·1 cites·6 claims
- 3970US9545389B2Baclofen and acamprosate based therapy of macular degeneration disordersPHARNEXT·Filed 2013·Granted Jan 17, 2017·1 cites·10 claims
- 4069US2020085790A1Baclofen and acamprosate based therapy of neurological disordersPHARNEXT·Filed 2019·Application pending·0 cites
- 4168US12226413B2Early treatment of CMT diseasePHARNEXT·Filed 2021·Granted Feb 18, 2025·0 cites·25 claims
- 4265US2018209997A1Diagnostic tools for charcot-marie-tooth diseasePHARNEXT·Filed 2018·Application pending·0 cites
- 4364US10617689B2Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose levelPHARNEXT·Filed 2016·Granted Apr 14, 2020·0 cites·20 claims
- 4464US2020222409A1Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose levelPHARNEXT·Filed 2020·Application pending·0 cites
- 4563US2015157626A1Therapeutic approaches for treating cmt and related disordersPHARNEXT·Filed 2015·Application pending·0 cites
- 4662US2017231958A1Baclofen and acamprosate based therapy of neurological disordersPHARNEXT·Filed 2017·Application pending·0 cites
- 4762US2021069135A1Therapeutic approaches for treating epilepsy and related disorders through reduction of epileptogenesisPHARNEXT·Filed 2020·Application pending·0 cites
- 4861US9945876B2Diagnostic tools for charcot-marie-tooth diseasePHARNEXT·Filed 2015·Granted Apr 17, 2018·0 cites·12 claims
- 4961US2015374647A1Therapeutic approaches for treating epilepsy and related disorders through reduction of epileptogenesisPHARNEXT·Filed 2013·Application pending·0 cites
- 5058US9789098B2Nootropic compositions for improving memory performancePHARNEXT·Filed 2013·Granted Oct 17, 2017·0 cites·12 claims
Showing the top 50 of 61 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →